Ben Johnson

7PUBLICATIONS
11CO-AUTHORS
Toxicology (incl. clinical toxicology)Medical physicsMajor global burdens of diseaseHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 29, 2026
Pain medication use in patients with X-linked hypophosphatemia treated with burosumab: a retrospective real-world study.

|Apr 04, 2026
Real-world Effectiveness of Burosumab Across Age Groups: X-linked Hypophosphatemia (XLH) Disease Monitoring Program.

Leanne M Ward, Thomas O Carpenter, Hamilton Cassinelli

|Nov 04, 2025
Delayed diagnosis of X-linked hypophosphatemia in the absence of family history: a global unmet need.

Suma Uday, M Zulf Mughal, Hamilton Cassinelli

|Jun 24, 2024
Healthcare Resource Use Associated With Tumor-Induced Osteomalacia: A Literature Review.

Suzanne M Jan de Beur, Kathryn M Dahir, Erik A Imel

|Apr 26, 2022
Cost-effectiveness of romosozumab for the treatment of postmenopausal women at very high risk of fracture in Canada.

Ron Goeree, Natasha Burke, Manon Jobin

|Oct 12, 2021
Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan.

Ben Johnson, Edward Chia-Cheng Lai, Huang-Tz Ou

Pageof 2

Frequent Collaborators

3 joint publications

Thomas O Carpenter

3 joint publications

Zhiyi Li

2 joint publications

Pablo Florenzano

2 joint publications

Leanne M Ward